Shareprice
14 Jun 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

sciencenews.dk: Fluorescent tumours will vastly improve survival for people with cancer

News


April 12, 2018

Read the article “Fluorescent tumours will vastly improve survival for people with cancer” here.